Newsletter | September 8, 2020

09.08.20 -- Scientists Develop First Drug-Like Compounds To Inhibit Elusive Cancer-Linked Enzymes

Industry Insights
4 Ways To Avoid Failure In Phase III Clinical Manufacturing

Understanding the challenges in the biopharma space is critical, as the planning you do today dictates the options you have later when the costs — and the stakes — get even higher.

Is Not Using A CDMO Slowing Down Your Process Development?

Consider what process development capabilities you have versus what you could possibly gain from working with a CDMO to not only be successful but also improve your chances of getting to market sooner.

Five Steps To Great Results Using One-Step Mulitplex RT-qPCR

One-step multiplex RT-qPCR is a technique used to rapidly quantify multiple targets directly from RNA in a single reaction. This blog explains the proper optimization and validation for successful one-step multiplex RT-qPCR as well as tips for choosing the right reagents for your needs.

Technology Selection For Bioavailability Enhancement

Due to the growing incidence of low drug solubility in the pharmaceutical discovery and development pipeline, the number of enabling technologies that are employed to improve oral drug absorption and bioavailability (BA) are growing. Rational selection methodologies across this array of technologies can improve chances of clinical success, reduce program complexity, and accelerate development timelines.

Anticipating The Formulation Challenges Of Complex Molecules

Due to the increasing complexity of today’s API molecules, formulation problems are arising with greater frequency, delaying development, and burdening developers with unanticipated and heavy costs.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.